OPEN END TURBO SHORT - VIRBAC Stock

Certificat

DE000ME6AV09

Real-time Bid/Ask 03:10:27 2024-06-06 EDT
4.08 EUR / 4.25 EUR -18.49% Intraday chart for OPEN END TURBO SHORT - VIRBAC
Current month+10.37%
1 month-2.48%
Date Price Change
24-06-05 5.11 +0.59%
24-06-04 5.08 +9.25%
24-06-03 4.65 +0.43%
24-05-31 4.63 -3.54%
24-05-30 4.8 -1.03%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 07:02 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying VIRBAC
Issuer Morgan Stanley
WKN ME6AV0
ISINDE000ME6AV09
Date issued 2024-01-03
Strike 399.7
Maturity Unlimited
Parity 10 : 1
Emission price 4.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.28
Lowest since issue 2.85
Spread 0.17
Spread %3.94%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
360 EUR
Average target price
373.3 EUR
Spread / Average Target
+3.70%
Consensus